Gastric Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. Jul 15, 2003; 9(7): 1415-1420
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1415
Figure 1
Figure 1 FasL was strongly expressed in moderately differentiated adenocarcinoma of stomach (+++). S-P × 400.
Figure 2
Figure 2 Caspase-3 was negatively expressed in poorly differentiated adenocarcinoma of stomach (-), while strongly positive in tumor infiltrating lymphocytes (+++). S-P × 400.
Figure 3
Figure 3 FasL was strongly expressed in gastric cancer cells of lymph node metastasis (+++). S-P × 400.
Figure 4
Figure 4 Caspase-3 was strongly expressed in gastric cancer cells of ovary metastasis (+++). S-P × 400.